| [1]Tsuda E, Goto M, Mochizuki S, et al.Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis[J].Biochem Biophys Res Commun,1997,234(1):137-142.[2]Simonet WS, Lacey DL, Dunstan CR, et al.Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.[3]Yasuda H,Shima N,Nakagawa N, et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J].Proc Natl Acad Sci U S A,1998,95(7):3597-3602.[4]Lacey DL, Timms E, Tan HL, et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998,93(2):165-176.[5]Yasuda H, Shima N, Nakagawa N, et al.Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro[J].Endocrinology,1998,139(3):1329-1337.[6]Mogi M, Otogoto J, Ota N, et al.Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis[J].J Dent Res,2004,83(2):166-169.[7]中华人民共和国科学技术部.关于善待实验动物的指导性意见. 2006-09-30. http://www.most.gov.cn/fggw/zfwj/zfwj2006/200609/t20060930_54389.htm[8]Union TEPatcotE.Directive on the release of genetically modified organisms (GMOs) Directive 2001/18/EC ANNEX I A. 2001 : 17[9]Jackson DA, Symons RH, Berg P.Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli[J].Proc Natl Acad Sci U S A,1972,69(10):2904-2909.[10]Nations FaAOotU.The process of genetic modification. Food and Agricultural Organisation of the United Nations. 2000 [S][11]Ramoshebi LN, Matsaba TN, Teare J, et al.T20 engineering: TGF-beta superfamily members and delivery systems in bone regeneration[J].Expert Rev Mol Med,2002,4(20):1-11.[12]Bartold PM, McCulloch CA, Narayanan AS, et al.T engineering: a new paradigm for periodontal regeneration based on molecular and cell biology[J].Periodontol 2000,2000,24:253-269.[13]李育阳.基因表达技术[M].北京:科学出版社,2001[14]王松灵，边专.口腔分子生物学与口腔实验动物模型[M]. 北京:人民卫生出版社,2011[15]靳小兵,孙永生,娄思权,等.寻找基因转染人脂肪来源的成体干细胞合适载体:脂质体介导质粒pEGFP-N1、重组腺病毒Ad5-EGFP与重组腺相关病毒rAAV-2/1-EGFP[J].中国组织工程研究与临床康复,2007,11(7):1205-1208.[16]陈欣戬,李艳芬,钟泉,等.人碱性成纤维细胞生长因子真核表达质粒的构建及其在犬牙龈成纤维细胞中的表达[J].牙体牙髓牙周病学杂志,2009,19(6):318-322.[17]Partridge KA, Oreffo RO.Gene delivery in bone t1/2 engineering: progress and prospects using viral and nonviral strategies[J].T1/2 Eng,2004,10(1/2):295-307.[18]Ballay A, Levrero M, Buendia MA, et al.In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses[J].EMBO J,1985,4(13B):3861-3865.[19]Park OJ, Shin SY, Choi Y, et al.The association of osteoprotegerin gene polymorphisms with periodontitis[J].Oral Dis,2008,14(5):440-444.[20]温进坤.医学分子生物学理论与研究技术. 2版. 北京:科学出版,2002[21]Hassell TM.T1s and cells of the periodontium[J].Periodontol 2000,1993,3(1):9-38.[22]Piche JE, Carnes DL Jr, Graves DT.Initial characterization of cells derived from human periodontia[J].J Dent Res,1989,68(5):761-767.[23]王燕, 汪说之, 樊明文, 等.牙周韧带细胞体外矿化的研究——骨唾蛋白与骨桥素在矿化过程中的表达[J].口腔医学纵横,2002,18(1):11-13.[24]van Dijk LJ, Schakenraad JM, van der Voort HM, et al.Cell-seeding of periodontal ligament fibroblasts. A novel technique to create new attachment. A pilot study[J].J Clin Periodontol,1991,18(3):196-199.[25]王长昇, 林建华, 吴朝阳, 等.重组腺病毒Ad5-hBDNF-EGFP的构建及体外转染大鼠间充质干细胞后基因表达[J].解剖学杂志,2011,34(5):637-640.[26]单志新, 林秋雄, 李晓红, 等.腺病毒表达载体对骨髓间充质干细胞分化能力的影响[J].南方医科大学学报,2008,28(7):1132-1135.[27]Arribillaga L, de Cerio AL, Sarobe P, et al.Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus[J].Vaccine,2002,21(3/4):202-210. |
